These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 32414711)

  • 81. Association of ACE2 receptor and ACEIs/ARBs with disease severity in COVID-19.
    Sinha S; Sehgal A; Sehgal R
    Drug Discov Ther; 2020; 14(4):161-170. PubMed ID: 32908071
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
    Pang X; Cui Y; Zhu Y
    Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
    [No Abstract]   [Full Text] [Related]  

  • 83. The renin-angiotensin-aldosterone system: Role in pathogenesis and potential therapeutic target in COVID-19.
    Braga CL; Silva-Aguiar RP; Battaglini D; Peruchetti DB; Robba C; Pelosi P; Rocco PRM; Caruso-Neves C; Silva PL
    Pharmacol Res Perspect; 2020 Aug; 8(4):e00623. PubMed ID: 32658389
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
    Wu C; Ye D; Mullick AE; Li Z; Danser AHJ; Daugherty A; Lu HS
    Hypertension; 2020 Oct; 76(4):e29-e30. PubMed ID: 32673509
    [No Abstract]   [Full Text] [Related]  

  • 85. The Cross-Talk between Age, Hypertension and Inflammation in COVID-19 Patients: Therapeutic Targets.
    Casucci G; Acanfora D; Incalzi RA
    Drugs Aging; 2020 Nov; 37(11):779-785. PubMed ID: 33084001
    [TBL] [Abstract][Full Text] [Related]  

  • 86. SARS-CoV-2 receptor ACE2-dependent implications on the cardiovascular system: From basic science to clinical implications.
    Groß S; Jahn C; Cushman S; Bär C; Thum T
    J Mol Cell Cardiol; 2020 Jul; 144():47-53. PubMed ID: 32360703
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Renin-angiotensin system at the heart of COVID-19 pandemic.
    Alifano M; Alifano P; Forgez P; Iannelli A
    Biochimie; 2020 Jul; 174():30-33. PubMed ID: 32305506
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Renin-Angiotensin-Aldosterone Inhibitors and COVID-19 Infection.
    Tsampasian V; Corballis N; Vassiliou VS
    Curr Hypertens Rep; 2022 Oct; 24(10):425-433. PubMed ID: 35716247
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Endocrine Significance of SARS-CoV-2's Reliance on ACE2.
    Lazartigues E; Qadir MMF; Mauvais-Jarvis F
    Endocrinology; 2020 Sep; 161(9):. PubMed ID: 32652001
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Severe respiratory SARS-CoV2 infection: Does ACE2 receptor matter?
    Perrotta F; Matera MG; Cazzola M; Bianco A
    Respir Med; 2020 Jul; 168():105996. PubMed ID: 32364961
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [ACE2 and coronavirus - a question of balance and dynamics?].
    Lundström A; Sandén P
    Lakartidningen; 2020 Apr; 117():. PubMed ID: 32314329
    [TBL] [Abstract][Full Text] [Related]  

  • 92. ACE2 and ACE: structure-based insights into mechanism, regulation and receptor recognition by SARS-CoV.
    Lubbe L; Cozier GE; Oosthuizen D; Acharya KR; Sturrock ED
    Clin Sci (Lond); 2020 Nov; 134(21):2851-2871. PubMed ID: 33146371
    [TBL] [Abstract][Full Text] [Related]  

  • 93. COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?
    Şen S; Üresin AY
    Turk Kardiyol Dern Ars; 2020 Oct; 48(7):631-634. PubMed ID: 33034579
    [No Abstract]   [Full Text] [Related]  

  • 94. COVID-19 and heart failure: from infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease.
    Tomasoni D; Italia L; Adamo M; Inciardi RM; Lombardi CM; Solomon SD; Metra M
    Eur J Heart Fail; 2020 Jun; 22(6):957-966. PubMed ID: 32412156
    [TBL] [Abstract][Full Text] [Related]  

  • 95. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes?
    Filardi T; Morano S
    J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299
    [TBL] [Abstract][Full Text] [Related]  

  • 96. ACE2 imbalance as a key player for the poor outcomes in COVID-19 patients with age-related comorbidities - Role of gut microbiota dysbiosis.
    Viana SD; Nunes S; Reis F
    Ageing Res Rev; 2020 Sep; 62():101123. PubMed ID: 32683039
    [TBL] [Abstract][Full Text] [Related]  

  • 97. SARS-CoV-2 & Covid-19: Key-Roles of the 'Renin-Angiotensin' System / Vitamin D Impacting Drug and Vaccine Developments.
    Cao Z; Wu Y; Faucon E; Sabatier JM
    Infect Disord Drug Targets; 2020; 20(3):348-349. PubMed ID: 32370727
    [No Abstract]   [Full Text] [Related]  

  • 98. COVID-19: ACE2centric Infective Disease?
    Verdecchia P; Cavallini C; Spanevello A; Angeli F
    Hypertension; 2020 Aug; 76(2):294-299. PubMed ID: 32476472
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Hypertension, the renin-angiotensin system, and the risk of lower respiratory tract infections and lung injury: implications for COVID-19.
    Kreutz R; Algharably EAE; Azizi M; Dobrowolski P; Guzik T; Januszewicz A; Persu A; Prejbisz A; Riemer TG; Wang JG; Burnier M
    Cardiovasc Res; 2020 Aug; 116(10):1688-1699. PubMed ID: 32293003
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.
    Tsioufis C; Dimitriadis K; Tousoulis D
    Hellenic J Cardiol; 2020; 61(1):31-33. PubMed ID: 32450334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.